Oncoscint Cancer Imaging: v. 6 (Targeted Diagnosis & Therapy Series)
Oncoscint Cancer Imaging: v. 6 (Targeted Diagnosis & Therapy Series) is backordered and will ship as soon as it is back in stock.
Couldn't load pickup availability
Genuine Products Guarantee
Genuine Products Guarantee
We guarantee 100% genuine products, and if proven otherwise, we will compensate you with 10 times the product's cost.
Delivery and Shipping
Delivery and Shipping
Products are generally ready for dispatch within 1 day and typically reach you in 3 to 5 days.
Oncoscint Cancer Imaging: v. 6 (Targeted Diagnosis & Therapy Se...
Author: Maguire, Robert T.
Binding: Hardcover
Format: Import
Number Of Pages: 260
Release Date: 01-01-1992
Details: This volume discusses the preclinical and clinical experience with the B72.3 monoclonal anti-body as a tumour targeting agent - emphasizing the results of studies utilizing site-specifically radiolabelled B72.3 (CYT-103-111In; OncoScint CR103). Focusing on OncoStint's ability to determine the presence and extent of disease in colorectal or ovarian cancer patients, this book: reviews the generation of the B72.3 monoclonal antibody and its development from preclinical trials to the first approved cancer imaging technology; presents the results of clinical trials of radioiodinated and indium-111 labelled material for colorectal cancer patients and considers the contribution of this procedure to their care; describes the use of CYT-103-111In as a presurgical diagnostic agent in ovarian cancer patients and its impact on their surgical management; and offers examples of normal biodistribution, tumour localization, and the potential pitfalls in image interpretation. The book is intended for radiologists, internists, oncologists, nuclear medicine physicians, gastroenterologists, obstetricians/gynaecologists, immunologists and surgeons.
EAN: 9780824786465
Package Dimensions: 9.1 x 6.6 x 1.1 inches
Languages: english
